| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_938a6d7a15cbc93a74abe1953eb25d47 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-706
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 |
| filingDate |
2013-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8b90c758b03626a5af29b7334f7b5d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98596673b0a8e5ebed2922b2b89e6b38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_506f1ecc3f5c20e2539112a866d0f23b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4f3b068fa18422817e77f949675c9b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77376e64a888c8eeebbc182ccbe61351
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c225542c4b4d1ffad517b7771f5c349c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c95e01937114cf17c6489b4295187ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2484f5b0f2348efbbabfd18018da9f11 |
| publicationDate |
2014-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
UY-34701-A |
| titleOfInvention |
SOLID FORMS OF A THIOPHOSPHORAMIDATE NUCLEOTIDE PROFIT |
| abstract |
The present application relates to solid state forms, for example, to crystalline forms of 2? C? Methyluridin? 5? (O? Phenyl? N? (S)? 1? (Isopropoxycarbonyl) ethyl) thiophosphoramidate, pharmaceutical compositions which may include one or more solid forms of 2? C? methyluridin? 5? (O? phenyl? N? (S)? 1? (isopropoxycarbonyl) ethyl) thiophosphoramidate, and methods for treating or improving diseases and / or conditions with one or more solid forms of 2? C? methyluridin? 5? (O? phenyl? N? (S)? 1? (isopropoxycarbonyl) ethyl) thiophosphoramidate. Methods for treating one or more solid forms of 2? C? Methyluridin? 5? (O? Phenyl? N? (S)? 1? (Isopropoxycarbonyl) ethyl) thiophosphoramidate in combination one or more others are also disclosed herein. Agents |
| priorityDate |
2012-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |